Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. - Wikidata - awgldk - TriplyDB

Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.

Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.

http://www.wikidata.org/entity/Q36853612

about

Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors Mast cells in inflammatory arthritis Bioactive lipids in Trypanosoma cruzi infection The Catalytic Architecture of Leukotriene C4 Synthase with Two Arginine Residues Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspective Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer Genetically manipulated mouse models of lung disease: potential and pitfalls Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Factors driving the aspirin exacerbated respiratory disease phenotype.Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells.A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice Following the path of CCL2 from prostaglandins to periostin in lung fibrosis Effect of early treatment with transcutaneous electrical diaphragmatic stimulation (TEDS) on pulmonary inflammation induced by bleomycin.CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells IL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins.Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis.Cytosolic phospholipase A₂: physiological function and role in disease.Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosis Eosinophils in the pathogenesis of allergic airways disease.Temporal dynamics of the developing lung transcriptome in three common inbred strains of laboratory mice reveals multiple stages of postnatal alveolar development The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia.Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruzi.Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function.Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.Opposing roles of leukotrienes and prostaglandins in fibrotic lung disease.Leukotriene pathway in sickle cell disease: a potential target for directed therapy.Cysteinyl leukotriene receptors, old and new; implications for asthma.Acute lung injury and pulmonary vascular permeability: use of transgenic models.Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury.BLT1 Mediates Bleomycin-Induced Lung Fibrosis Independently of Neutrophils and CD4+ T Cells.Extracellular matrix remodeling by dynamic strain in a three-dimensional tissue-engineered human airway wall model.Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.Animal models of chronic experimental asthma - strategies for the identification of new therapeutic targets.

P2860

Q24546541-5D7D3644-6A35-40CE-9373-9B42DCC8752B Q24646354-3969C99E-B490-4897-8AB2-7755F04430A0 Q24798636-AF27EF17-885B-471E-96CA-63B0608E9F7C Q26866224-DD2202D7-913C-4D0B-98D9-8F2E1E4860BF Q27667376-A4AA7519-E6D3-4F46-BF72-1B676BDF9A2B Q28067073-0E0275F9-F772-4156-B536-F4F42457D393 Q28212087-17A05CF1-1FA4-419D-83A1-6E5339CA5A3C Q28219122-8C893AF4-B639-41F9-94F4-9F1BBF8699B7 Q28308101-71FDEFED-E0F9-4B10-8A91-2165C5F2735D Q28388821-2256AD34-BCF8-40F5-A718-CA7932E0F752 Q30275780-B7A65C2B-F6C7-4EE9-8AB6-3767316EBA53 Q30300955-18595A11-F5CA-4FC7-B231-8A70F59E758B Q30428747-3FEE6ACC-A251-447D-9AD2-4FA7BE13B561 Q30438955-B91CD008-4DDD-49A9-B71C-3989BE0FDEA0 Q33765936-95EDD582-88DC-4C0D-98C8-BEB9D59E14EA Q33799756-76928FAB-78F8-4CFD-BAC5-5AB5917313C3 Q34391970-8DCDCC7A-E5A0-4883-97AF-B94B2373847A Q34662206-BCD5AF44-39B9-447C-B3F6-0DA153805A1D Q34971386-F57E63B8-5562-46E9-BF2A-6E4527BE6421 Q35083565-13F1AEA6-3425-4AD0-BF23-A58F59D6D4A9 Q35882459-D21E8C1E-DC27-422E-9641-3FA6911BEB1C Q35886245-15A51961-FA71-4611-9692-4A0B98FDD230 Q36013692-F4136521-6F79-4BE8-937D-74E8650636FA Q36059786-ECB49EE3-3BF8-4E5B-AFE5-73CFDE169709 Q36124996-F3D9FB98-CD87-43E8-BE58-47D49BE4B793 Q36216154-3B002A02-F847-4194-9111-C9956814DB89 Q36691584-6BAEC7A3-B376-4FE4-862F-3AD8F40236B7 Q36711106-ABE55FAA-D05B-44C2-BA98-F660D094CB17 Q36822323-FF5FBA62-EE67-48D4-921E-AD7ECC8DEE9F Q36970702-267FF1DF-CF3D-4D43-8670-145AC2B7AD2F Q37261678-5DFA2DA5-9DE6-4F04-8C2B-C490419AE3FD Q37754750-4E34E4B2-EDF7-40A6-9F1B-73EA2327B77A Q37810108-067B9A5A-BFC3-422A-93D8-BBFCD54D1CCB Q38038319-D1C11729-A6FF-4949-9A7F-406A50668D3E Q38112059-7EF43089-D63C-41C6-B559-98F749FE2CF4 Q40324025-79066BD8-9EFF-43BC-98AB-650C980F9536 Q40385076-12487EFB-BBF4-412B-842E-CBA2DBD299ED Q42136339-1487E5CB-7C0F-4569-9822-C3968DD1E305 Q43055697-6CD30F6F-9CB5-449C-AAA6-E565933DE28B Q43065050-565557F8-579B-4B6D-887F-65310A3F004E

P2860

Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.

http://www.wikidata.org/entity/Q36853612

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Cysteinyl leukotriene 1 recept ...... ary inflammation and fibrosis.

@en

type

label

Cysteinyl leukotriene 1 recept ...... ary inflammation and fibrosis.

@en

prefLabel

Cysteinyl leukotriene 1 recept ...... ary inflammation and fibrosis.

@en

P1433

Q36853612-C5707A0A-53D3-4158-8035-18F0193681A2

P1476

Q36853612-8F9715AF-0B91-4CD8-B5C1-5A0A8F0A3D26

P2093

Q36853612-34EF855D-3590-41B0-9C77-706E222E90E7

Q36853612-35FE6512-B3DE-4C73-AA54-C0B60A9097A1

Q36853612-49B86D74-EDF0-4D61-84E8-28FA5CE57661

Q36853612-9C2E8363-12EB-47BC-B420-71FCFE3B667C

Q36853612-D812B29B-75DA-48DE-BACA-55CA7AE64B10

Q36853612-E88B50B3-2876-4DBE-B5D2-243E89482246

P2860

Q36853612-0257B69D-00F3-47F7-B952-9921F9680A0D

Q36853612-03C724F4-A452-430A-BB07-B0F7480C02FE

Q36853612-1218FB94-9401-4191-8777-B20E10B9CE07

Q36853612-4471947B-D6ED-41AA-B041-0FD013DB60BF

Q36853612-52C8A0A8-EE42-47D6-8FBA-2A4A0D97898D

Q36853612-5705772F-FE4B-457A-B32A-80376B129268

Q36853612-5F460D93-6561-41F1-9319-36625D2B3671

Q36853612-6186564C-92F3-4928-BCAD-7C1790BDCD41

Q36853612-61A0E249-ACFE-416F-BF91-5E1CA7A89E54

Q36853612-65D10FF1-4542-4319-87F9-BEE1BAA33B75

P304

Q36853612-D3F118A0-82A5-4943-B716-DEA776A6F728

P31

Q36853612-89520A79-6A21-4813-974E-2B0E5DF70E0D

P356

Q36853612-E649EEAD-DA5D-4029-8BD7-B0043E300A19

P407

Q36853612-6F6074CE-6B75-4C27-BA51-6EE181288D06

P433

Q36853612-05B20E65-FEBE-4A5C-89BC-2D4BD7D2F0E0

P478

Q36853612-30231CFC-9C8A-4578-B687-4B5D1DEBC2C3

P577

Q36853612-C5598AAE-9B93-41E9-A9E1-B7A9051FDEA0

P5875

Q36853612-25E129D6-AB17-46A6-A7C9-395656AA819F

P698

Q36853612-B0BD5DD9-2568-43EF-92C2-57787C7ECD0A

P932

Q36853612-F4A36EE0-D314-49CE-BD00-B758DF01C26C

P356

PNAS.0400235101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Cysteinyl leukotriene 1 recept ...... ary inflammation and fibrosis.

@en

P2093

Akiko Maekawa

http://www.w3.org/2001/XMLSchema#string

Bing K Lam

http://www.w3.org/2001/XMLSchema#string

Daniel S Friend

http://www.w3.org/2001/XMLSchema#string

K Frank Austen

http://www.w3.org/2001/XMLSchema#string

Thomas C Beller

http://www.w3.org/2001/XMLSchema#string

Yoshihide Kanaoka

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the human cysteinyl leukotriene CysLT1 receptor

The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor

The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock

Interconversion of leukotrienes catalyzed by purified gamma-glutamyl transpeptidase: concomitant formation of leukotriene D4 and gamma-glutamyl amino acids.

Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor

Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing

Resolution of lung inflammation by CD44

Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution

The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization

The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils

P304

3047-3052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0400235101

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5787614

http://www.w3.org/2001/XMLSchema#string

P698

14970333

http://www.w3.org/2001/XMLSchema#string

P932

365742

http://www.w3.org/2001/XMLSchema#string